Biogen to gain from Novo Nordisk Alzheimer’s failure, says Jefferies
Go back to Biogen to gain from Novo Nordisk Alzheimer’s failure, says Jefferies| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 221.60 +3.48 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.12 | 52 Week High | $333.65 | |||
| Open | $218.93 | 52 Week Low | $223.02 | |||
| Day High | $222.28 | P/E | 28.37 | |||
| Day Low | $218.00 | EPS | $7.81 | |||
| Volume | 179,830 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 48.09 +1.17 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.92 | 52 Week High | $59.00 | |||
| Open | $47.84 | 52 Week Low | $32.80 | |||
| Day High | $48.50 | P/E | N/A | |||
| Day Low | $47.56 | EPS | $0.00 | |||
| Volume | 8,893,861 | |||||
